These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evolving immunosuppressive regimens for lung transplant recipients. Meyer NJ; Bhorade SM Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus for the prevention and treatment of rejection of solid organ transplants. Scalea JR; Levi ST; Ally W; Brayman KL Expert Rev Clin Immunol; 2016; 12(3):333-42. PubMed ID: 26588770 [TBL] [Abstract][Full Text] [Related]
8. [Controversies about the use of calcineurin inhibitors in pediatric patients]. Dello Strologo L G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303 [TBL] [Abstract][Full Text] [Related]
9. Clinical Challenges of Tacrolimus for Maintenance Immunosuppression Post-Lung Transplantation. Ivulich S; Dooley M; Kirkpatrick C; Snell G Transplant Proc; 2017 Nov; 49(9):2153-2160. PubMed ID: 29149976 [TBL] [Abstract][Full Text] [Related]
10. Induction immunosuppression for combined heart-lung transplantation. Hayes D; McConnell PI; Yates AR; Tobias JD; Galantowicz M; Mansour HM; Tumin D Clin Transplant; 2016 Oct; 30(10):1332-1339. PubMed ID: 27490992 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
12. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406 [TBL] [Abstract][Full Text] [Related]
14. An overview of immunosuppression in solid organ transplantation. Enderby C; Keller CA Am J Manag Care; 2015 Jan; 21(1 Suppl):s12-23. PubMed ID: 25734416 [TBL] [Abstract][Full Text] [Related]
15. [Modern immunosuppression after solid organ transplantation]. Beimler J; Morath C; Zeier M Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922 [TBL] [Abstract][Full Text] [Related]
16. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in uterus transplantation: from transplant to delivery. D'Amico G; Del Prete L; Eghtesad B; Hashimoto K; Miller C; Tzakis A; Quintini C; Falcone T Expert Opin Pharmacother; 2023 Jan; 24(1):29-35. PubMed ID: 35723045 [TBL] [Abstract][Full Text] [Related]
18. [Recent options in drug therapy after solid organ transplantation]. Pőcze B; Németh P; Langer R Orv Hetil; 2012 Aug; 153(33):1294-301. PubMed ID: 22890176 [TBL] [Abstract][Full Text] [Related]
19. New directions for induction immunosuppression strategy in solid organ transplantation. Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743 [TBL] [Abstract][Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]